July 26, 2018
CRH Medical (TSX:CRH; NYSE:CRHM) has announced it has completed an accretive transaction where it has acquired a 51 percent interest...
April 23, 2018
Takeda Pharmaceuticals may become a top global drugmaker with positions in treatments for cancers, gastrointestinal diseases and nervous-system disorders.
March 28, 2018
Interpace Diagnostics (NASDAQ:IDXG) a fully integrated commercial and bioinformatics company that provides clinically useful molecular diagnostic tests and pathology services...
March 26, 2018
TiGenix (NASDAQ: TIG) and Takeda Pharmaceutical (TSE: 4502) announced that the European Commission (EC) has approved Alofisel (darvadstrocel), previously Cx601,...
February 7, 2018
Here, the Investing News Network looks at publicly traded medical device and technology companies listed on the TSX.
November 16, 2017
GT Biopharma announced the appointment of Shawn Cross as president and COO of the company.
August 18, 2017
Ritter Pharmaceuticals announced its phase 3 plans after their end-of-phase 2 meeting with the FDA for RP-G28 treating lactose intolerance.